梅州医长期盆腔炎机构医院(梅州眼部整形修复术) (今日更新中)

NOBLESVILLE, Ind. -- Jason Seaman, the hero teacher who stopped a school shooter at Noblesville West Middle School Friday, was honored at a baseball game Monday morning.The game was an Indiana Sectional Championship baseball game between Noblesville High School and Hamilton Southeastern High School. A moment of silence was held before Seaman arrived, then students began chanting Seaman's name, "Mis-ter Sea-man!"In an especially powerful moment, Seaman walked to some of his students who wanted to see him, with a fence separating them. The students said they were glad to see him, and he gave them some high-fives.Watch video of the interaction with the students in the player above. Police say Seaman, 29, tackled a student who started firing in his classroom Friday morning. He was shot three times during the incident, but released from the hospital Saturday. Noblesville Schools is selling T-shirts to raise money for Seaman and the other victim in the shooting, Ella Whistler. Whistler's family said she is doing well at Riley Hospital for Children. Noblesville sold out of T-shirts at the game, raising more than ,000 for Seaman and Whistler.  1199

New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn’t mean protection also is gone or that it won’t be possible to develop an effective vaccine.“Infection with this coronavirus does not necessarily generate lifetime immunity,” but antibodies are only part of the story, said Dr. Buddy Creech, an infectious disease specialist at Vanderbilt University. He had no role in the work, published Tuesday in the New England Journal of Medicine.The immune system remembers how to make fresh antibodies if needed and other parts of it also can mount an attack, he said.Antibodies are proteins that white blood cells called B cells make to bind to the virus and help eliminate it. The earliest ones are fairly crude but as infection goes on, the immune system becomes trained to focus its attack and to make more precise antibodies.Dr. Otto Yang and others at the University of California, Los Angeles, measured these more precise antibodies in 30 patients diagnosed with COVID-19 and four housemates presumed to have the disease. Their average age was 43 and most had mild symptoms.Researchers found that the antibodies had a half-life of 73 days, which means that half of them would be gone after that much time. It dovetails with a previous report from China also suggesting antibodies quickly fade.The results “call for caution regarding antibody-based ‘immunity passports,’ herd immunity, and perhaps vaccine durability,” the California authors write.That’s true, Creech said, but other parts of the immune system also help confer protection. Besides churning out antibodies, B cells develop a memory so they know how to do that again if needed.“They would get called into action very quickly when there’s a new exposure to the virus. It’s as if they lie dormant, just waiting,” he said.Other white blood cells called T cells also are better able to attack the virus the next time they see it, Creech said.Although circulating antibodies may not last long, what we need to know is if and how people remake antibodies if exposed to the coronavirus again and if they protect against another infection, Alison Criss, an immunologist at the University of Virginia, wrote in an email. “We also need to know if there is a protective T cell response” that reappears.Vaccines, which provoke the immune system to make antibodies, might give longer-lasting protection than natural infection because they use purified versions of what stimulates that response, she noted.Creech agreed.“This shouldn’t dissuade us from pursuing a vaccine,” he said. “Antibodies are only a part of the story.”___Marilynn Marchione can be followed on Twitter at http://twitter.com/MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 2967

New results on a possible COVID-19 vaccine from Oxford University and drugmaker AstraZeneca suggest it is safe and about 70% effective.Some experts say that shows it is likely to win approval, but questions remain about how well it may help protect those over 55. That's a key concern for a vaccine that health officials hope to rely on around the world because of its low cost, availability and ease of use.Partial results from tests of the vaccine in the United Kingdom, Brazil and South Africa were published Tuesday by the medical journal Lancet.“Today, we have published the interim analysis of the Phase III trial and show that this new vaccine has a good safety record and efficacy against the coronavirus,” said Professor Andrew Pollard, Director of the Oxford Vaccine Group and Chief Investigator of the Oxford Vaccine Trial. “We are hugely grateful to our trial volunteers for working with us over the past eight months to bring us to this milestone.”Researchers claim the vaccine protected against disease in 62% of those given two full doses and in 90% of those initially given the half dose. However, independent experts have said the second group was too small — 2,741 people — to judge the possible value of that approach and more testing is needed.The interim analysis for efficacy was based on 11,636 participants accruing 131 symptomatic infections from the Phase III trials.In addition to the Oxford led program, AstraZeneca is conducting a large study in the US and globally. In total, Oxford University and AstraZeneca expect to enroll more than 60,000 participants globally.The company says it’s also making progress in manufacturing with a capacity of up to 3 billion doses of the vaccine in 2021 on a rolling basis, pending regulatory approval. The vaccine can be stored, transported and handled at normal refrigerated conditions for at least six months and administered within existing health care settings. 1940

NEW YORK – A New York City police officer was among the several people arrested in connection to a drug trafficking bust, officials announced Monday.NYPD officer Amaury Abreu and two other men, Julia Bautista and Gustavo Valerio, are accused of conspiring to import and distribute cocaine.The three men were allegedly members of a multinational drug trafficking organization with distributors in the New York area and the Dominican Republic between January 2016 and October 2020.Bautista, 35, and Valerio, 38, were high-ranking members of the organization based in New York and were responsible for distributing and overseeing the distribution of cocaine once it was in New York, according to the federal complaint.Abreu, 34, allegedly used his position as a police officer and provided information about law enforcement procedures, performing warrant checks on DTO members, on at least one instance, distributed cocaine for the group.Officials said Abreu pleaded not guilty to the charges and was released on a million bond with home detention as a condition of the bond.Two other men face changes in connection to the bust. Cesar Diaz-Bautista, 43, faces charges of possession with the intent to distribute cocaine, while Junior Ortiz, 29, faces charges of cocaine importation conspiracy.Ortiz was released on a 0,000 bond and Diaz-Bautista will be released on a 0,000 bond, officials said.The other two defendants had not yet been arraigned Monday.Since 2016, law enforcement agents have seized more than 350 kilograms of cocaine belonging to the DTO.“This criminal network allegedly trafficked more than 350 kilos of cocaine and was assisted by an NYPD officer, who used his knowledge and access to help them stay one step ahead of the law,” stated District Attorney Madeline Singas.“There is no place for corruption in the NYPD and it will always be prosecuted fully. We commend our IAB investigators and law enforcement partners in this case,” said Police Commissioner Dermot Shea said in a statement.Abreu has been suspended without pay, according to an NYPD spokesperson.This story was originally published by Kristine Garcia at WPIX. 2159

Nine-year-old Nariya White loves to concoct slime and make lip gloss. She's an aspiring scientist and an expert at turning simple ingredients into original products. So when she was bullied this past school year, she turned that experience into something positive.“Two girls were bullying me, and I just decided I should make a book about bullying," said White.In March, she wrote a book called "A Slimetastic Day." It was recently published and is available on Amazon.The book is about "encouragement." When two boys call girls dumb, the girls initially become discouraged, but then the girls challenge the boys to slime making competition. The girls use their creativity and knowledge to prevail. White hopes her book inspires other children.“The book was about bullying, so if someone in your school or on the street is bullying you, you shouldn’t really care about it because you have your family, cousins, and friends that care about you," White said.White's mother Kina knew the book would be a bestseller with family and friends but said she didn't expect all the praise they've received from strangers. She hoped publishing the book would help spread the word.“I thought it was important just to make other people aware that you can turn a negative into a positive, and I know that there are many kids that are dealing with the same situation and many parents," said Kina White.The young author leaves her readers with this message, on the book's last page."From that day on, the girls knew that anything boys could do so could girls."WKBW's Gilat Melamed first reported this story. 1598

来源：资阳报